This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ nandrolone,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Muscle Wasting: Nandrolone is often prescribed to treat muscle wasting conditions such as cachexia (wasting syndrome) associated with chronic illnesses like HIV/AIDS, cancer, or other diseases. It helps promote muscle growth and weight gain, improving overall muscle mass and strength.

  2. Anemia: Nandrolone can stimulate the production of red blood cells, which may be beneficial in the treatment of anemia, particularly in individuals with conditions such as chronic kidney disease, aplastic anemia, or myelofibrosis. By increasing red blood cell production, nandrolone can improve oxygen transport in the body and alleviate symptoms of anemia such as fatigue and weakness.

  3. Hormone Imbalances: In some cases, nandrolone may be used to address hormone imbalances, particularly in men with conditions such as hypogonadism (low testosterone levels). It can help restore testosterone levels to within the normal range, improving symptoms such as low libido, fatigue, and reduced muscle mass.

  4. Osteoporosis: While not a primary indication, nandrolone has been studied for its potential role in the treatment of osteoporosis, a condition characterized by weakened bones and increased risk of fractures. Some research suggests that nandrolone may have beneficial effects on bone density and strength, potentially reducing the risk of fractures in individuals with osteoporosis.

  5. Recovery from Surgery or Injury: Nandrolone may be used to promote recovery from surgery, trauma, or severe injury by enhancing protein synthesis, reducing muscle breakdown, and improving overall recovery time. However, its use for this purpose is controversial and not widely recommended due to potential side effects and risks associated with long-term steroid use.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of nandrolone,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Bifidobacterium longum Reduces
species Lacticaseibacillus paracasei Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by nandrolone,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Dorea genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Bacteroides genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Bilophila genus Decreases
0 1 Coprococcus genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Lachnospira genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Odoribacter genus Decreases
0 1 Enterocloster genus Decreases
0 1 Thomasclavelia genus Decreases
1 0 Akkermansia genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Enterocloster bolteae species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Coprococcus comes species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Fusobacterium nucleatum species Decreases
0 1 Akkermansia glycaniphila species Decreases
1 0 Lachnospira eligens species Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases

Impact of nandrolone,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.7 0.7
Acne 0.6 0.7 -0.17
ADHD 1.4 0.6 1.33
Age-Related Macular Degeneration and Glaucoma 0.6 0.6
Allergic Rhinitis (Hay Fever) 1.2 0.5 1.4
Allergies 1.5 2 -0.33
Allergy to milk products 0.9 0.6 0.5
Alopecia (Hair Loss) 0.6 0.6
Alzheimer's disease 2.5 2.6 -0.04
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.8 0.4 3.5
Ankylosing spondylitis 1.5 1.2 0.25
Anorexia Nervosa 0.6 1.2 -1
Antiphospholipid syndrome (APS) 0.4 0.3 0.33
Asthma 2.2 0.7 2.14
Atherosclerosis 1.2 0.5 1.4
Atrial fibrillation 2 0.9 1.22
Autism 3.1 3.1 0
Autoimmune Disease 0.3 0.3 0
Barrett esophagus cancer 0.3 0.3
benign prostatic hyperplasia 0.3 -0.3
Biofilm 0 0
Bipolar Disorder 0.9 0.6 0.5
Brain Trauma 0.3 0.9 -2
Breast Cancer 0.6 0.3 1
Cancer (General) 0.6 0.6 0
Carcinoma 2.3 1.7 0.35
Celiac Disease 0.6 2.5 -3.17
Cerebral Palsy 0.6 0.6 0
Chronic Fatigue Syndrome 1.6 2.6 -0.63
Chronic Kidney Disease 1.3 1.3 0
Chronic Lyme 0.3 -0.3
Chronic Obstructive Pulmonary Disease (COPD) 0.6 0.9 -0.5
Chronic Urticaria (Hives) 0.1 -0.1
Coagulation / Micro clot triggering bacteria 0.3 -0.3
Cognitive Function 1.5 0.6 1.5
Colorectal Cancer 2.9 0.9 2.22
Constipation 0.9 0.3 2
Coronary artery disease 0.3 0.9 -2
COVID-19 2.8 3.2 -0.14
Crohn's Disease 2.7 2.7 0
Cushing's Syndrome (hypercortisolism) 0.3 -0.3
cystic fibrosis 0.6 -0.6
deep vein thrombosis 0.6 0.6 0
Denture Wearers Oral Shifts 0 0
Depression 4.1 3.1 0.32
Dermatomyositis 0.3 -0.3
Eczema 0.3 0.9 -2
Endometriosis 1.4 1.2 0.17
Eosinophilic Esophagitis 0.3 0.3
Epilepsy 0.9 0.7 0.29
erectile dysfunction 1.1 0.3 2.67
Fibromyalgia 1.4 0.7 1
Functional constipation / chronic idiopathic constipation 1.9 1.6 0.19
gallstone disease (gsd) 0.9 0.6 0.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.3 0.3 0
Generalized anxiety disorder 0.9 1 -0.11
Gout 1.8 0.9 1
Graves' disease 0.9 1.7 -0.89
Gulf War Syndrome 0.3 0.8 -1.67
Halitosis 0.6 0.6
Hashimoto's thyroiditis 2.2 1.6 0.38
Heart Failure 0.9 0.6 0.5
hemorrhagic stroke 0.9 0.9
Hidradenitis Suppurativa 1.2 1.2
High Histamine/low DAO 0.6 -0.6
hypercholesterolemia (High Cholesterol) 0.3 0.1 2
hyperglycemia 0.6 0.7 -0.17
Hyperlipidemia (High Blood Fats) 0.6 0.6
hypersomnia 0.3 -0.3
hypertension (High Blood Pressure 2.2 2.4 -0.09
Hypothyroidism 0 0.6 0
Hypoxia 1.2 0.3 3
IgA nephropathy (IgAN) 0.9 0.8 0.13
Inflammatory Bowel Disease 1.9 2.7 -0.42
Insomnia 1.5 1 0.5
Intelligence 0.6 0.6
Intracranial aneurysms 0.9 0.6 0.5
Irritable Bowel Syndrome 2.4 1.6 0.5
ischemic stroke 1.1 0.3 2.67
Liver Cirrhosis 2.6 3 -0.15
Long COVID 2.8 3.6 -0.29
Low bone mineral density 0.6 -0.6
Lung Cancer 0.3 0.9 -2
Lymphoma 0.3 0.3
Mast Cell Issues / mastitis 0 0.9 0
ME/CFS with IBS 0.3 0.8 -1.67
ME/CFS without IBS 1.3 -1.3
Menopause 0.2 0 0
Metabolic Syndrome 3.1 3.2 -0.03
Mood Disorders 3.5 1.9 0.84
multiple chemical sensitivity [MCS] 0 0
Multiple Sclerosis 2 1.3 0.54
Multiple system atrophy (MSA) 0.1 0.6 -5
neuropathic pain 1.1 -1.1
Neuropathy (all types) 0 0.2 0
neuropsychiatric disorders (PANDAS, PANS) 0.3 0.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.6 2 0.3
NonCeliac Gluten Sensitivity 0.6 0.6 0
Obesity 4.7 3.9 0.21
obsessive-compulsive disorder 0.7 2.2 -2.14
Osteoarthritis 0.8 0.9 -0.13
Osteoporosis 0.6 1.2 -1
pancreatic cancer 0.6 0.3 1
Parkinson's Disease 2.7 2.9 -0.07
Polycystic ovary syndrome 1.5 1.5 0
Postural orthostatic tachycardia syndrome 0.6 -0.6
Premenstrual dysphoric disorder 0.3 0.3
primary biliary cholangitis 0.6 0.3 1
Primary sclerosing cholangitis 0.6 0.6 0
Psoriasis 0.8 0.6 0.33
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.7 2 0.35
Rosacea 1 0.3 2.33
Schizophrenia 2.5 1.5 0.67
scoliosis 0.3 0.6 -1
Sjögren syndrome 0.3 1.2 -3
Sleep Apnea 2 0.9 1.22
Slow gastric motility / Gastroparesis 0.6 0.3 1
Small Intestinal Bacterial Overgrowth (SIBO) 0.9 0.1 8
Stress / posttraumatic stress disorder 1.5 0.9 0.67
Systemic Lupus Erythematosus 1.4 1.2 0.17
Tic Disorder 0.6 0.9 -0.5
Tourette syndrome 0.6 0.3 1
Type 1 Diabetes 1.8 1.7 0.06
Type 2 Diabetes 2.9 2.9 0
Ulcerative colitis 2 2.3 -0.15
Unhealthy Ageing 2.5 0.9 1.78
Vitiligo 1.2 0.4 2

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]